FP7H2020
Bayer Pharma AG
- Country
- DEGermany
- Defence projects
- 0
- Projects, all programmes
- 30
- As coordinator
- 1
- EU contribution (CORDIS)
- EUR 1,340,999
- Active
- 2009 to 2018
Projects
30 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| CaReSyAnCombatting the CardioRenal Syndrome: towards an integrative Analysis to reduce cardiovascular burden in chronic kidney disease | H2020 | 2018 | Partner | EUR 0 |
| HARMONYHealthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026 | H2020 | 2017 | Participant | EUR 0 |
| IB4SD-TRISTANImaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106 | H2020 | 2017 | Participant | EUR 0 |
| BEAt-DKDBiomarker Enterprise to Attack DKD - Sofia ref.: 115974 | H2020 | 2016 | Participant | EUR 0 |
| PREFERPatient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 | H2020 | 2016 | Participant | EUR 0 |
| IDEASImproving Design, Evaluation and Analysis of early drug development Studies | H2020 | 2015 | Participant | EUR 249,216 |
| ADAPT-SMARTAccelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: 115890 | H2020 | 2015 | Participant | EUR 0 |
| MAGICBULLETPeptide-Drug Conjugates for Targeted Delivery in Tumor Therapy | H2020 | 2015 | Partner | EUR 0 |
| ENLIGHT-TENEuropean Network linking informatics and genomics of helper T cells | H2020 | 2015 | Participant | EUR 103,840 |
| WEB-RADRRecognising Adverse Drug Reactions | FP7 | 2014 | Participant | Not stated |
| CanDoA CANcer Development mOnitor | FP7 | 2014 | Participant | EUR 253,685 |
| GETREALIncorporating real-life clinical data into drug development | FP7 | 2013 | Participant | Not stated |
| RADOXRADical reduction of OXidative stress in cardiovascular diseases | FP7 | 2013 | Participant | EUR 95,400 |
| EUPATIEuropean Patients' Academy on Therapeutic Innovation | FP7 | 2012 | Participant | Not stated |
| ABIRISKAnti-Biopharmaceutical Immunization:Prediction and analysis of clinical relevance to minimize the risk | FP7 | 2012 | Participant | Not stated |
| CHEM21Chemical Manufacturing Methods for the 21st Century Pharmaceutical Industries | FP7 | 2012 | Participant | Not stated |
| PREDICTPredicting individual response and resistance to VEGFR/mTOR pathway therapeutic intervention using biomarkers discovered through tumour functional genomics | FP7 | 2011 | Participant | EUR 328,700 |
| EPC-TM-NETTargeting the tumour microenvironment to improve pancreatic cancer prognosis | FP7 | 2011 | Participant | EUR 76,462 |
| EHR4CRElectronic Health Record systems for Clinical Research | FP7 | 2011 | Participant | Not stated |
| PREDECTNew Models for Preclinical Evaluation of Drug Efficacy in Common Solid Tumours | FP7 | 2011 | Participant | Not stated |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.